VRSN up +1.15% percent right now. $VRSN High is at 60.72

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
VRSN up +1.15% percent right now. $VRSN High is at 60.72 and the Low 59.51 with current volume of 618,450.

Recent News posted below.

VRSN Verisign Inc Recent Headline News

VeriSign Earnings In Retrospect: Up 6.1% in the Last 18 Days (VRSN)
Comtex SmarTrend(R) - 2 hrs 8 mins ago
When VeriSign (NASDAQ:VRSN) reported earnings 18 days ago on October 23rd, 2014, analysts, on average, expected the company to report earnings of $0.69 on sales of $252.9 million. The company actually reported EPS of $0.70 on sales of $255.0 million, beating EPS estimates by $0.01 and beating revenue estimates by $2.2 million. Shares of VeriSign have climbed from $56.34 to $59.80, representing a gain of 6.1% since the company reported earnings 18 days ago.
VRSN: 60.39 (+0.59)

20 Stocks That Could Beat the Market in November: Priceline, U.S. Steel Lead Way
at The Street - Wed Nov 05, 10:24AM CST
Which stocks have historically done the best in November, typically one of the best months to invest?
BIIB: 327.14 (+6.39), MNST: 107.30 (-1.09), ATI: 31.82 (-0.86), MON: 116.84 (+2.40), GMCR: 155.05 (+2.15), VMC: 65.40 (+0.29), EMR: 65.01 (+0.15), WDC: 97.63 (-0.07), VRSN: 60.39 (+0.59), URBN: 30.53 (-0.65), FSLR: 51.86 (+1.57), DE: 88.41 (-0.25), EXPE: 85.97 (+0.86), FLR: 65.93 (-0.36), FLS: 67.77 (-0.13), X: 36.71 (-0.86), ROK: 112.64 (+0.35), REGN: 385.85 (+8.01), MA: 84.94 (+0.14)

Internet Software and Services Stocks on the Move - Yahoo!, Twitter, Conversant, VeriSign, and GrubHub
PR Newswire - Wed Oct 29, 7:30AM CDT
Investor-Edge has initiated coverage on the following equities: Yahoo! Inc. (NASDAQ: YHOO), Twitter Inc. (NYSE: TWTR), Conversant Inc. (NASDAQ: CNVR), VeriSign Inc. (NASDAQ: VRSN), and GrubHub Inc. (NYSE: GRUB). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, October 28, 2014, the NASDAQ Composite ended at 4,564.29, up 1.75%, the Dow Jones Industrial Average advanced 1.12%, to finish the day at 17,005.75, and the S&P 500 closed at 1,985.05, up 1.19%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Information Technology Sector Index ended the day at 658.82, up 1.42%, with the index also advancing 2.28% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
VRSN: 60.39 (+0.59), YHOO: 49.37 (+0.82), GRUB: 33.57 (+0.32), TWTR: 39.67 (-0.64), CNVR: 34.92 (-0.18)

VeriSign Posts Strong Q3 with Earnings, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:45AM CDT
VeriSign Inc. (VRSN) reported third-quarter 2014 earnings (excluding all one-time items but including stock-based compensation) of 81 cents per share, which increased 35% from 60 cents in the year-ago quarter.
VRSN: 60.40 (+0.60), T: 35.07 (+0.16), VZ: 50.75 (-0.11), GOOG: 547.40 (+6.39)

Update: Verisign And The Importance Of Brand Power
Early Retiree - at Seeking Alpha - Fri Oct 24, 7:47AM CDT

VRSN: 60.40 (+0.60)

VeriSign's (VRSN) CEO James Bidzos on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 6:30PM CDT

VRSN: 60.40 (+0.60)

VeriSign (VRSN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 3:25PM CDT

VRSN: 60.40 (+0.60)

VeriSign beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 3:19PM CDT

VRSN: 60.40 (+0.60)

Verisign Reports Third Quarter 2014 Results
Marketwired - Thu Oct 23, 3:07PM CDT
VeriSign, Inc. (NASDAQ: VRSN), a global leader in domain names and Internet security, today reported financial results for the third quarter of 2014.
VRSN: 60.40 (+0.60)

Short Sellers Catch Recent Downturn
Markit - at Seeking Alpha - Mon Oct 20, 5:36AM CDT
The recent market downturn has seen shorts add to their already elevated positions in the wake of the S&P's 7% decline in the last month, which saw the most shorted companies fall by over twice the index average. In contrast to the events of...
PBCT: 14.86 (+0.05), VRSN: 60.40 (+0.60), KSS: 56.57 (-0.65), DO: 37.21 (-1.53), BTU: 11.28 (-0.36), WU: 18.23 (+0.35), GME: 42.71 (-0.98), CLF: 11.19 (+0.02), X: 36.71 (-0.86), ADT: 36.75 (+0.55)

12 Stocks Warren Buffett Loves in 2014
at The Street - Mon Oct 13, 9:28AM CDT
Here's a look at 12 stocks Buffett's Berkshire Hathaway bought in the most recently reported quarter.
CBI: 54.59 (-0.99), CHTR: 146.87 (-9.50), WMT: 79.65 (+0.88), SU: 34.32 (-0.25), VRSN: 60.40 (+0.60), V: 249.99 (-2.44), IBM: 163.73 (+1.66), LBTYA: 45.91 (-0.69), USB: 43.91 (+0.10), USG: 27.84 (+0.01), GM: 31.08 (-0.51), BRK.B: 144.98 (+1.37), VZ: 50.75 (-0.11), BRK.A: 217,400.00 (+2,430.00)

Verisign to Report Third Quarter 2014 Financial Results
Marketwire - Wed Oct 01, 3:05PM CDT
VeriSign, Inc. (NASDAQ: VRSN), a global leader in domain names and Internet security, announced that its earnings call for the third quarter of 2014 will take place on Thursday, Oct. 23, 2014, at 4:30 p.m. (EDT).
VRSN: 60.40 (+0.60)

VeriSign Rises 1.59% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Sep 24, 5:19PM CDT
VeriSign (NASDAQ:VRSN) traded in a range yesterday that spanned from a low of $55.37 to a high of $56.40. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $56.25 on volume of 877,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRSN: 60.40 (+0.60)

VeriSign Set to Possibly Pullback After Yesterday's Rally of 1.59%
Comtex SmarTrend(R) - Wed Sep 24, 5:18PM CDT
VeriSign (NASDAQ:VRSN) traded in a range yesterday that spanned from a low of $55.37 to a high of $56.40. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $56.25 on volume of 877,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRSN: 60.40 (+0.60)

Stock Watchout on Internet Software and Services Industry - Conversant, Millennial Media, Pandora Media, VeriSign, and Criteo
PR Newswire - Mon Sep 22, 7:45AM CDT
The US markets on Friday, September 19, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,279.74, up 0.08% and the NASDAQ Composite closed at 4,579.79, down 0.30%. The S&P 500 finished the session 0.05% lower at 2,010.40. During the trading session, six out of ten sectors finished on a positive note. The S&P 500 Information Technology Sector Index ended the day at 668.32, down 0.36%, whereas the index has advanced 6.63% in the previous three months. Investor-Edge has initiated coverage on the following equities: Conversant Inc. (NASDAQ: CNVR), Millennial Media Inc. (NYSE: MM), Pandora Media Inc. (NYSE: P), VeriSign Inc. (NASDAQ: VRSN), and Criteo S.A. (NASDAQ: CRTO). Free research on these five companies can be accessed at:
VRSN: 60.40 (+0.60), P: 18.50 (-0.01), CRTO: 36.28 (+0.09), MM: 1.94 (+0.07), CNVR: 34.91 (-0.19)

VeriSign Has Returned 10.8% Since SmarTrend Recommendation (VRSN)
Comtex SmarTrend(R) - Thu Sep 11, 5:16PM CDT
SmarTrend identified an Uptrend for VeriSign (NASDAQ:VRSN) on June 6th, 2014 at $51.04. In approximately 3 months, VeriSign has returned 10.76% as of today's recent price of $56.53.
VRSN: 60.40 (+0.60)

Is IBM’s Watson Supercomputer Smart Enough to Up the Firm’s Profit?
at The Street - Mon Sep 08, 7:00AM CDT
Could the machine figure out how to increase the annual profit of IBM from $16.5 billion to $22.8 billion, which is what Microsoft makes?
AMZN: 305.13 (+5.27), AKAM: 60.97 (+0.84), FB: 74.99 (-0.61), TSM: 22.27 (+0.45), CA: 29.91 (-0.14), WLP: 125.51 (+1.36), CTXS: 66.86 (+0.54), ORCL: 40.45 (+0.51), SYMC: 25.08 (+0.11), VRSN: 60.40 (+0.60), FISV: 69.85 (+0.39), IBM: 163.73 (+1.66), RJF: 56.85 (+0.41), GOOGL: 558.02 (+6.20), TWTR: 39.67 (-0.64), DOX: 47.48 (-0.03), MSFT: 48.94 (+0.26), CHKP: 74.70 (+0.03)

Shares of VRSN Up 11.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Sep 04, 11:23AM CDT
SmarTrend identified an Uptrend for VeriSign (NASDAQ:VRSN) on June 6th, 2014 at $51.04. In approximately 3 months, VeriSign has returned 11.84% as of today's recent price of $57.08.
VRSN: 60.40 (+0.60)

SmarTrend Watching for Potential Pullback in Shares of VeriSign After 1.07% Gain
Comtex SmarTrend(R) - Fri Aug 29, 4:35PM CDT
VeriSign (NASDAQ:VRSN) traded in a range yesterday that spanned from a low of $56.55 to a high of $57.43. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $57.31 on volume of 828,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRSN: 60.40 (+0.60)

Look for Shares of VeriSign to Potentially Pullback after Yesterday's 1.07% Rise
Comtex SmarTrend(R) - Fri Aug 29, 4:34PM CDT
VeriSign (NASDAQ:VRSN) traded in a range yesterday that spanned from a low of $56.55 to a high of $57.43. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $57.31 on volume of 828,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRSN: 60.40 (+0.60)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading